498 related articles for article (PubMed ID: 30012102)
1. A longitudinal magnetic resonance imaging study of neurodegenerative and small vessel disease, and clinical cognitive trajectories in non demented patients with transient ischemic attack: the PREVENT study.
Tariq S; d'Esterre CD; Sajobi TT; Smith EE; Longman RS; Frayne R; Coutts SB; Forkert ND; Barber PA
BMC Geriatr; 2018 Jul; 18(1):163. PubMed ID: 30012102
[TBL] [Abstract][Full Text] [Related]
2. Cerebral small vessel disease, medial temporal lobe atrophy and cognitive status in patients with ischaemic stroke and transient ischaemic attack.
Arba F; Quinn T; Hankey GJ; Ali M; Lees KR; Inzitari D;
Eur J Neurol; 2017 Feb; 24(2):276-282. PubMed ID: 27862654
[TBL] [Abstract][Full Text] [Related]
3. Correlating Cognitive Decline with White Matter Lesion and Brain Atrophy Magnetic Resonance Imaging Measurements in Alzheimer's Disease.
Bilello M; Doshi J; Nabavizadeh SA; Toledo JB; Erus G; Xie SX; Trojanowski JQ; Han X; Davatzikos C
J Alzheimers Dis; 2015; 48(4):987-94. PubMed ID: 26402108
[TBL] [Abstract][Full Text] [Related]
4. Alzheimer's and neurodegenerative disease biomarkers in blood predict brain atrophy and cognitive decline.
Dark HE; An Y; Duggan MR; Joynes C; Davatzikos C; Erus G; Lewis A; Moghekar AR; Resnick SM; Walker KA
Alzheimers Res Ther; 2024 Apr; 16(1):94. PubMed ID: 38689358
[TBL] [Abstract][Full Text] [Related]
5. MarkVCID cerebral small vessel consortium: I. Enrollment, clinical, fluid protocols.
Wilcock D; Jicha G; Blacker D; Albert MS; D'Orazio LM; Elahi FM; Fornage M; Hinman JD; Knoefel J; Kramer J; Kryscio RJ; Lamar M; Moghekar A; Prestopnik J; Ringman JM; Rosenberg G; Sagare A; Satizabal CL; Schneider J; Seshadri S; Sur S; Tracy RP; Yasar S; Williams V; Singh H; Mazina L; Helmer KG; Corriveau RA; Schwab K; Kivisäkk P; Greenberg SM;
Alzheimers Dement; 2021 Apr; 17(4):704-715. PubMed ID: 33480172
[TBL] [Abstract][Full Text] [Related]
6. Cerebrovascular resistance: effects on cognitive decline, cortical atrophy, and progression to dementia.
Yew B; Nation DA;
Brain; 2017 Jul; 140(7):1987-2001. PubMed ID: 28575149
[TBL] [Abstract][Full Text] [Related]
7. Biomarker clusters are differentially associated with longitudinal cognitive decline in late midlife.
Racine AM; Koscik RL; Berman SE; Nicholas CR; Clark LR; Okonkwo OC; Rowley HA; Asthana S; Bendlin BB; Blennow K; Zetterberg H; Gleason CE; Carlsson CM; Johnson SC
Brain; 2016 Aug; 139(Pt 8):2261-74. PubMed ID: 27324877
[TBL] [Abstract][Full Text] [Related]
8. Effects of amyloid pathology and neurodegeneration on cognitive change in cognitively normal adults.
Bilgel M; An Y; Helphrey J; Elkins W; Gomez G; Wong DF; Davatzikos C; Ferrucci L; Resnick SM
Brain; 2018 Aug; 141(8):2475-2485. PubMed ID: 29901697
[TBL] [Abstract][Full Text] [Related]
9. The Brain Chart of Aging: Machine-learning analytics reveals links between brain aging, white matter disease, amyloid burden, and cognition in the iSTAGING consortium of 10,216 harmonized MR scans.
Habes M; Pomponio R; Shou H; Doshi J; Mamourian E; Erus G; Nasrallah I; Launer LJ; Rashid T; Bilgel M; Fan Y; Toledo JB; Yaffe K; Sotiras A; Srinivasan D; Espeland M; Masters C; Maruff P; Fripp J; Völzk H; Johnson SC; Morris JC; Albert MS; Miller MI; Bryan RN; Grabe HJ; Resnick SM; Wolk DA; Davatzikos C;
Alzheimers Dement; 2021 Jan; 17(1):89-102. PubMed ID: 32920988
[TBL] [Abstract][Full Text] [Related]
10. Cerebrospinal fluid neurogranin: relation to cognition and neurodegeneration in Alzheimer's disease.
Portelius E; Zetterberg H; Skillbäck T; Törnqvist U; Andreasson U; Trojanowski JQ; Weiner MW; Shaw LM; Mattsson N; Blennow K;
Brain; 2015 Nov; 138(Pt 11):3373-85. PubMed ID: 26373605
[TBL] [Abstract][Full Text] [Related]
11. Neuropsychological and neuroimaging assessments of early cognitive impairment in patients after mild ischemic stroke and transient ischemic attack.
Yang Y; Ye L; Lin R; Lin H; Tang T; Chen Y; Zhang J; Wang L
J Integr Neurosci; 2020 Jun; 19(2):313-319. PubMed ID: 32706195
[TBL] [Abstract][Full Text] [Related]
12. Entorhinal Perfusion Predicts Future Memory Decline, Neurodegeneration, and White Matter Hyperintensity Progression in Older Adults.
Bangen KJ; Thomas KR; Sanchez DL; Edmonds EC; Weigand AJ; Delano-Wood L; Bondi MW;
J Alzheimers Dis; 2021; 81(4):1711-1725. PubMed ID: 33967041
[TBL] [Abstract][Full Text] [Related]
13. Independent effects of white matter hyperintensities on cognitive, neuropsychiatric, and functional decline: a longitudinal investigation using the National Alzheimer's Coordinating Center Uniform Data Set.
Puzo C; Labriola C; Sugarman MA; Tripodis Y; Martin B; Palmisano JN; Steinberg EG; Stein TD; Kowall NW; McKee AC; Mez J; Killiany RJ; Stern RA; Alosco ML
Alzheimers Res Ther; 2019 Jul; 11(1):64. PubMed ID: 31351489
[TBL] [Abstract][Full Text] [Related]
14. A data-driven model of biomarker changes in sporadic Alzheimer's disease.
Young AL; Oxtoby NP; Daga P; Cash DM; Fox NC; Ourselin S; Schott JM; Alexander DC;
Brain; 2014 Sep; 137(Pt 9):2564-77. PubMed ID: 25012224
[TBL] [Abstract][Full Text] [Related]
15. Longitudinal structural cerebral changes related to core CSF biomarkers in preclinical Alzheimer's disease: A study of two independent datasets.
Falcon C; Tucholka A; Monté-Rubio GC; Cacciaglia R; Operto G; Rami L; Gispert JD; Molinuevo JL;
Neuroimage Clin; 2018; 19():190-201. PubMed ID: 30023169
[TBL] [Abstract][Full Text] [Related]
16. White matter tract microstructure and cognitive performance after transient ischemic attack.
Tariq S; Tsang A; Wang M; Reaume N; Carlson H; Sajobi TT; Longman RS; Smith EE; Frayne R; d'Esterre CD; Coutts SB; Barber PA
PLoS One; 2020; 15(10):e0239116. PubMed ID: 33095770
[TBL] [Abstract][Full Text] [Related]
17. Risk Factors and Cognitive Relevance of Cortical Cerebral Microinfarcts in Patients With Ischemic Stroke or Transient Ischemic Attack.
Wang Z; van Veluw SJ; Wong A; Liu W; Shi L; Yang J; Xiong Y; Lau A; Biessels GJ; Mok VC
Stroke; 2016 Oct; 47(10):2450-5. PubMed ID: 27539302
[TBL] [Abstract][Full Text] [Related]
18. Longitudinal neuroimaging biomarkers differ across Alzheimer's disease phenotypes.
Sintini I; Graff-Radford J; Senjem ML; Schwarz CG; Machulda MM; Martin PR; Jones DT; Boeve BF; Knopman DS; Kantarci K; Petersen RC; Jack CR; Lowe VJ; Josephs KA; Whitwell JL
Brain; 2020 Jul; 143(7):2281-2294. PubMed ID: 32572464
[TBL] [Abstract][Full Text] [Related]
19. Design and first baseline data of the DZNE multicenter observational study on predementia Alzheimer's disease (DELCODE).
Jessen F; Spottke A; Boecker H; Brosseron F; Buerger K; Catak C; Fliessbach K; Franke C; Fuentes M; Heneka MT; Janowitz D; Kilimann I; Laske C; Menne F; Nestor P; Peters O; Priller J; Pross V; Ramirez A; Schneider A; Speck O; Spruth EJ; Teipel S; Vukovich R; Westerteicher C; Wiltfang J; Wolfsgruber S; Wagner M; Düzel E
Alzheimers Res Ther; 2018 Feb; 10(1):15. PubMed ID: 29415768
[TBL] [Abstract][Full Text] [Related]
20. Alzheimer's disease pattern of brain atrophy predicts cognitive decline in Parkinson's disease.
Weintraub D; Dietz N; Duda JE; Wolk DA; Doshi J; Xie SX; Davatzikos C; Clark CM; Siderowf A
Brain; 2012 Jan; 135(Pt 1):170-80. PubMed ID: 22108576
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
